
Biomea Fusion Inc BMEA.OQ BMEA.O is expected to show no change in quarterly revenue when it reports results on May 2 (estimated) for the period ending March 31 2025
LSEG's mean analyst estimate for Biomea Fusion Inc is for a loss of 61 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Biomea Fusion Inc is $22.00, above its last closing price of $2.20.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -0.92 | -0.81 | Beat | 12.1 | |
Sep. 30 2024 | -0.91 | -0.95 | -0.91 | Beat | 4.2 |
Jun. 30 2024 | -1.07 | -1.07 | -1.03 | Beat | 3.8 |
Mar. 31 2024 | -0.99 | -0.99 | -1.09 | Missed | -9.6 |
Dec. 31 2023 | -0.82 | -0.85 | -0.98 | Missed | -15.1 |
Sep. 30 2023 | -0.82 | -0.82 | -0.80 | Beat | 2.8 |
Jun. 30 2023 | -0.90 | -0.88 | -0.70 | Beat | 20 |
Mar. 31 2023 | -0.82 | -0.81 | -0.98 | Missed | -20.9 |
This summary was machine generated April 30 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)